Oscotec Inc. (KOSDAQ:039200)

South Korea flag South Korea · Delayed Price · Currency is KRW
40,000
-800 (-1.96%)
Oct 30, 2025, 3:30 PM KST
-1.96%
Market Cap1.53T
Revenue (ttm)43.34B
Net Income (ttm)4.25B
Shares Out38.26M
EPS (ttm)23.09
PE Ratio359.72
Forward PE179.37
Dividendn/a
Ex-Dividend Daten/a
Volume147,401
Average Volume223,720
Open41,100
Previous Close40,800
Day's Range39,550 - 41,600
52-Week Range21,600 - 47,950
Beta1.76
RSI46.43
Earnings DateNov 14, 2025

About Oscotec

Oscotec Inc. operates as a biotechnology company, engages in the drug development, functional materials and related products, and dental bone graft material businesses. It develops SKI-O-703, a SYK inhibitor that is in Phase 2 clinical trials to treat rheumatoid arthritis and idiopathic thrombocytopenic purpura; SKI-G-801, a selective FLT3/AXL inhibitor, which is in Phase I clinical trial for the treatment of acute myeloid leukemia, as well as other solid tumors; and lazertinib, a 3rd generation EGFR inhibitor that is in Phase 3 clinical trials... [Read more]

Sector Healthcare
Founded 1998
Employees 53
Stock Exchange KOSDAQ
Ticker Symbol 039200
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.